An aging population, fast-paced advances in medicine and ethical concerns are calling for innovations in drug development. The Frankfurt-based biotech start-up Genome Biologics aims at revolutionising the way medication is developed and tested. Made possible by the support of the European Enterprise Network, Genome Biologics’ recent success as participants of the Horizon 2020 SME Instrument programme has put the company on the map.
Read the whole story of Genome Biologics
Stuttgart-based start-up Visioverdis wants to improve the urban environment with innovative façade gardens, because more plants mean a cleaner and healthier atmosphere in rapidly growing cities. With the support of the Enterprise Europe Network, not only can this idea work in Germany, but in the cities of the Middle East and Asia too, thereby making a significant contribution to climate protection.
Read the whole story of Visioverdis
Anna Yona felt it was time for Wildling Shoes to grow as much as her ambitions. So she contacted the Enterprise Europe Network to know all the advantages offered by the single market. The Enterprise Europe Network helped her find the right sources of new capital, loans or grants to bring her company to a higher level.
Read the whole story of Wildling Shoes